kabutan

Delta-Fly Pharma, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Widens

Fri Feb 13, 2026 3:35 pm JST Earnings

4598 Delta-Fly Pharma, Inc. 【J-GAAP】

Earnings Report

Delta-Fly Pharma, Inc. <4598> [TSE Growth] announced its financial results after the market closed on February 13th (15:35). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2026 (April to December) was a reduced loss of 1.24 billion yen (compared to a loss of 1.30 billion yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the January to March period (4Q) is expected to further decrease loss of 0.26 billion yen (compared to a loss of 0.41 billion yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the net loss expanded to loss of 0.40 billion yen (compared to a loss of 0.39 billion yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 0 -949 -971 -972 -142.1 ー Feb 13, 2024 J-GAAP
Apr - Dec, 2024 0 -1,293 -1,305 -1,307 -153.9 ー Feb 14, 2025 J-GAAP
Apr - Dec, 2025 0 -1,234 -1,246 -1,248 -110.7 ー Feb 13, 2026 J-GAAP
YoY － +4.6% +4.5% +4.5% +28.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 0 -792 -803 -804 -91.4 0 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance ー -669 -670 -671 -55.2 0 Nov 14, 2025 J-GAAP
YoY － +15.5% +16.6% +16.5% +39.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 0 -1,403 -1,426 -1,429 -198.8 0 May 15, 2024 J-GAAP
Mar, 2025 0 -1,708 -1,718 -1,721 -195.6 0 May 15, 2025 J-GAAP
Mar, 2026 Guidance ー -1,500 -1,510 -1,512 -124.4 0 May 15, 2025 J-GAAP
YoY － +12.2% +12.1% +12.1% +36.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 0 -377 -390 -390 -45.9 -Inf Feb 14, 2025 J-GAAP
Jan - Mar, 2025 0 -415 -413 -414 -47.1 -Inf May 15, 2025 J-GAAP
Apr - Jun, 2025 0 -358 -366 -367 -35.4 -Inf Aug 8, 2025 J-GAAP
Jul - Sep, 2025 0 -473 -474 -474 -43.4 -Inf Nov 14, 2025 J-GAAP
Oct - Dec, 2025 0 -403 -406 -407 -36.1 -Inf Feb 13, 2026 J-GAAP
YoY － -6.9% -4.1% -4.4% +21.4%

Related Articles